Arax Advisory Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.7M | Buy |
60,057
+44,676
| +290% | +$3.6M | 0.03% | 506 |
|
|
2026
Q1 | $1.29M | Sell |
15,381
-11,982
| -44% | -$1.15M | 0.04% | 368 |
|
|
2025
Q4 | $2.63M | Sell |
27,363
-22,008
| -45% | -$2.14M | 0.08% | 192 |
|
|
2025
Q3 | $4.7M | Buy |
49,371
+41,866
| +558% | +$3.85M | 0.07% | 239 |
|
|
2025
Q2 | $654K | Sell |
7,505
-4,710
| -39% | -$399K | 0.03% | 326 |
|
|
2025
Q1 | $1.1M | Buy |
12,215
+9,815
| +409% | +$878K | 0.07% | 171 |
|
|
2024
Q4 | $192K | Buy |
2,400
+980
| +69% | +$84.8K | 0.01% | 496 |
|
|
2024
Q3 | $128K | Buy |
1,420
+283
| +25% | +$23.8K | 0.01% | 444 |
|
|
2024
Q2 | $89.5K | Buy |
1,137
+401
| +54% | +$32.9K | 0.01% | 492 |
|
|
2024
Q1 | $64.2K | Sell |
736
-8
| -1% | -$683 | 0.01% | 451 |
|
|
2023
Q4 | $61.3K | Buy |
744
+13
| +2% | +$991 | 0.01% | 436 |
|
|
2023
Q3 | $57.3K | Sell |
731
-51
| -7% | -$4.27K | 0.01% | 438 |
|
|
2023
Q2 | $68.9K | Buy |
782
+128
| +20% | +$11K | 0.01% | 415 |
|
|
2023
Q1 | $52.8K | Buy |
654
+1
| +0.2% | +$82 | 0.01% | 452 |
|
|
2022
Q4 | $50.8K | Sell |
653
-28
| -4% | -$2.27K | 0.01% | 444 |
|
|
2022
Q3 | $55K | Buy |
681
+95
| +16% | +$8.54K | 0.01% | 415 |
|
|
2022
Q2 | $53K | Buy |
586
+1
| +0.2% | +$101 | 0.01% | 416 |
|
|
2022
Q1 | $65K | Buy |
585
+58
| +11% | +$6.13K | 0.01% | 414 |
|
|
2021
Q4 | $55K | Buy |
527
+455
| +632% | +$52.7K | 0.01% | 444 |
|
|
2021
Q3 | $9K | Hold |
72
| – | – | ﹤0.01% | 664 |
|
|
2021
Q2 | $9K | Buy |
+72
| New | +$9.04K | ﹤0.01% | 679 |
|
|
2020
Q4 | $250K | Buy |
2,131
+38
| +2% | +$4.18K | 0.04% | 179 |
|
|
2020
Q3 | $217K | Sell |
2,093
-668
| -24% | -$67.1K | 0.04% | 177 |
|
|
2020
Q2 | $253K | Sell |
2,761
-320
| -10% | -$30.7K | 0.05% | 137 |
|
|
2020
Q1 | $278K | Sell |
3,081
-250
| -8% | -$26.6K | 0.06% | 106 |
|
|
2019
Q4 | $378K | Sell |
3,331
-244
| -7% | -$26.8K | 0.11% | 83 |
|
|
2019
Q3 | $388K | Sell |
3,575
-503
| -12% | -$52.5K | 0.12% | 80 |
|
|
2019
Q2 | $397K | Buy |
+4,078
| New | +$372K | 0.13% | 75 |
|
|
2018
Q4 | $390K | Sell |
4,285
-226
| -5% | -$21.1K | 0.16% | 73 |
|
|
2018
Q3 | $444K | Sell |
4,511
-921
| -17% | -$85.1K | 0.18% | 67 |
|
|
2018
Q2 | $465K | Buy |
5,432
+1,424
| +36% | +$119K | 0.2% | 52 |
|
|
2018
Q1 | $321K | Buy |
4,008
+149
| +4% | +$12.3K | 0.17% | 59 |
|
|
2017
Q4 | $311K | Buy |
3,859
+34
| +0.9% | +$2.72K | 0.13% | 63 |
|
|
2017
Q3 | $297K | Buy |
3,825
+488
| +15% | +$40.5K | 0.14% | 64 |
|
|
2017
Q2 | $296K | Buy |
3,337
+1,035
| +45% | +$87.3K | 0.14% | 63 |
|
|
2017
Q1 | $185K | Buy |
2,302
+327
| +17% | +$25.5K | 0.09% | 72 |
|
|
2016
Q4 | $141K | Buy |
+1,975
| New | +$155K | 0.07% | 83 |
|
Other funds holding MDT
Arax Advisory Partners's MDT Position: Q2 2026 in Review
Arax Advisory Partners increased its Medtronic (MDT) stake by 290% in Q2 2026, buying an estimated $3.6M and bringing the position to 60,057 shares worth $4.7M. The position accounts for 0.03% of the portfolio, ranked #506.
Arax Advisory Partners first reported a position in MDT in Q4 2016 and has held it in 37 quarters since. The position peaked at $4.7M in Q3 2025. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Arax Advisory Partners held 60,057 shares of Medtronic worth $4.7M as of Q2 2026.
- Arax Advisory Partners bought 44,676 Medtronic shares in Q2 2026, an estimated $3.6M.
- Medtronic made up 0.03% of Arax Advisory Partners's portfolio in Q2 2026, its #506 holding.
- Arax Advisory Partners first reported a position in Medtronic in Q4 2016 and has held it in 37 quarters since.
- Arax Advisory Partners's Medtronic position peaked at $4.7M in Q3 2025.
- 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.